Viewing Study NCT00721669


Ignite Creation Date: 2025-12-24 @ 10:48 PM
Ignite Modification Date: 2026-02-21 @ 9:25 PM
Study NCT ID: NCT00721669
Status: COMPLETED
Last Update Posted: 2013-09-13
First Post: 2008-07-22
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase I Dose-Escalation Study of IMGN388 in Patients With Solid Tumors
Sponsor: ImmunoGen, Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module